EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Diagnostic Utility of Dorsolateral Nigral Hyperintensity with Susceptibility Map‐Weighted Imaging in Degenerative Parkinsonism Compared to Other Movement Disorders

Nathaniel Bendahan iD, Laura Armengou-Garcia iD, Mia Mojica, Riccardo Ludovichetti, Taryn J Rohringer, Bension Tilley, Alexandre Boutet, Anthony Lang, Paula Alcaide-Leon

Movement Disorders Clinical Practice · 2025

DOI: 10.1002/mdc3.70472 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Nathaniel Bendahan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Dorsolateral Prefrontal Cortex, Magnetic Resonance Imaging, Parkinsonian Disorders, Neurodegenerative Diseases. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Loss of dorsolateral nigral hyperintensity (DNH), also known as the swallow tail sign, on iron‐sensitive MRI is a promising imaging marker for neurodegenerative parkinsonism. Susceptibility Map‐Weighted Imaging (SMWI), an advanced MRI technique incorporating quantitative susceptibility mapping, has demonstrated superior contrast‐to‐noise ratio for detecting this feature, but has only been evaluated in small cohorts.

Objective

Determine the diagnostic accuracy of SMWI in degenerative parkinsonism and other neurological conditions.

Methods

We conducted a retrospective, diagnostic accuracy study of patients who underwent 3.0 T MRI with SMWI at our institution. Clinical diagnosis by neurologists served as the reference standard. Controls included patients with other movement disorders or neurological conditions. Two blinded readers assessed the presence of DNH independently, with discrepancies resolved by a senior neuroradiologist.

Results

A total of 248 patients were analyzed for the diagnostic accuracy of DNH using SMWI. Overall, the sensitivity was 92.0% (95% CI: 87.1–95.2%) and the specificity 95.8% (95% CI: 88.5–98.6%), for differentiating degenerative parkinsonism from other neurological conditions with excellent interrater reliability ( κ = 0.88). The sensitivity for Parkinson's disease (PD) was 93.2% and 88.4% for atypical parkinsonism and remained high in early PD (88.2%) and in patients with mild motor disability (94.2%).

Conclusions

SMWI is an accurate and reproducible imaging technique for diagnosing neurodegenerative parkinsonism, comparable to previously reported DAT‐scan accuracy. Other sequences used to assess the DNH such as regular Susceptibility Weighted Imaging have shown variable results, particularly when studying disease controls. These findings support the adoption of SMWI as a standard commercial sequence in clinical MRI platforms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dorsolateral Prefrontal CortexMagnetic Resonance ImagingParkinsonian DisordersNeurodegenerative DiseasesSubstantia NigraSensitivity and SpecificityBrain MappingSignal-To-Noise RatioContrast MediaBiomarkersReproducibility of ResultsRetrospective StudiesCross-Sectional StudiesImage Processing, Computer-AssistedHumansMaleFemaleMiddle AgedAgedAged, 80 and overReference Values

Stichwörter der Autor:innen

Parkinson'sdorsolateral nigral hyperintensityneuroimagingsusceptibility map‐weighted imaging (SMWI)swallow tail sign

Substanzen

Contrast MediaBiomarkers

Autor:innen und Institutionen

  • Division of Neurology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Edmond J. Safra and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
  • Slaight Family Centre for Advanced MRI, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
  • Division of Neuroradiology, Joint Department of Medical Imaging, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Department of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, Zurich, Switzerland.

ORCID-Profile: Nathaniel Bendahan, Laura Armengou-Garcia

Zitieren

APA

Bendahan, N., Armengou-Garcia, L., Mojica, M., Ludovichetti, R., Rohringer, T. J., Tilley, B., Boutet, A., Lang, A., & Alcaide-Leon, P. (2025). Diagnostic Utility of Dorsolateral Nigral Hyperintensity with Susceptibility Map‐Weighted Imaging in Degenerative Parkinsonism Compared to Other Movement Disorders. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70472

Vancouver

Bendahan N, Armengou-Garcia L, Mojica M, Ludovichetti R, Rohringer TJ, Tilley B, et al. Diagnostic Utility of Dorsolateral Nigral Hyperintensity with Susceptibility Map‐Weighted Imaging in Degenerative Parkinsonism Compared to Other Movement Disorders. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.70472

BibTeX
@article{Bendahan2025,
  author = {Bendahan, Nathaniel and Armengou-Garcia, Laura and Mojica, Mia and Ludovichetti, Riccardo and Rohringer, Taryn J and Tilley, Bension and Boutet, Alexandre and Lang, Anthony and Alcaide-Leon, Paula},
  title = {Diagnostic Utility of Dorsolateral Nigral Hyperintensity with Susceptibility Map‐Weighted Imaging in Degenerative Parkinsonism Compared to Other Movement Disorders},
  journal = {Movement Disorders Clinical Practice},
  year = {2025},
  doi = {10.1002/mdc3.70472}
}
Kostenlos starten →